Literature DB >> 30459206

Correction for Giuntini et al., "Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection".

Serena Giuntini1, Matteo Stoppato1, Maja Sedic1, Monir Ejemel1, Jessica R Pondish1, Danielle Wisheart1, Zachary A Schiller1, William D Thomas1, Eileen M Barry2, Lisa A Cavacini1, Mark S Klempner1, Yang Wang1.   

Abstract

Entities:  

Year:  2018        PMID： 30459206      PMCID： PMC6246902          DOI： 10.1128/IAI.00713-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  4 in total

1.  Escherichia coli phage phi2013: genomic analysis and receptor identification.

Authors:  Donghang Li; Zhiqiang Zhang; Yueying Li; Xixi Zhang; Xuying Qin; Dongsheng Wei; Hongjiang Yang
Journal:  Arch Virol       Date:  2022-10-04       Impact factor: 2.685

2.  Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants.

Authors:  Audrey Y-H Teh; Lisa Cavacini; Yue Hu; Ozan S Kumru; Jian Xiong; David T Bolick; Sangeeta B Joshi; Clemens Grünwald-Gruber; Friedrich Altmann; Mark Klempner; Richard L Guerrant; David B Volkin; Yang Wang; Julian K-C Ma
Journal:  Gut Microbes       Date:  2021 Jan-Dec

3.  Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.

Authors:  Alla Amcheslavsky; Aaron L Wallace; Monir Ejemel; Qi Li; Conor T McMahon; Matteo Stoppato; Serena Giuntini; Zachary A Schiller; Jessica R Pondish; Jacqueline R Toomey; Ryan M Schneider; Jordan Meisinger; Raimond Heukers; Andrew C Kruse; Eileen M Barry; Brian G Pierce; Mark S Klempner; Lisa A Cavacini; Yang Wang
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

Review 4.  Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.

Authors:  Eric Y Lin; Paul C Adamson; Jeffrey D Klausner
Journal:  Drugs       Date:  2021-06-07       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.